BIO-key International, Inc.
BKYI
$0.79
$0.0212.73%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 41.65% | 59.79% | 36.44% | 69.77% | 65.05% |
| Total Depreciation and Amortization | 0.92% | 48.96% | 6.26% | 7.72% | -29.64% |
| Total Amortization of Deferred Charges | 278.10% | 7.95% | -4.17% | 3.20% | -96.30% |
| Total Other Non-Cash Items | -115.10% | -104.56% | -102.66% | -65.59% | -68.11% |
| Change in Net Operating Assets | 245.51% | -283.06% | -84.44% | 157.19% | -2,433.16% |
| Cash from Operations | 66.40% | -665.45% | -753.73% | 115.40% | 19.42% |
| Capital Expenditure | 1,100.00% | -- | -- | -- | 98.04% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 1,100.00% | -- | -- | -- | 99.24% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 63.23% | 57.81% | -61.82% | -21.87% | -1,321.92% |
| Issuance of Common Stock | -- | -- | -86.33% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 96.01% | -429.13% | -- | -- | -1,019.33% |
| Cash from Financing | -153.48% | 2,203.49% | 24,678.75% | -57.14% | -16.38% |
| Foreign Exchange rate Adjustments | -114.27% | 1,145.35% | 37.50% | -224.85% | 526.76% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -767.40% | 309.29% | 463.46% | 109.36% | 246.87% |